Connection

Viswanathan Ramakrishnan to National Heart, Lung, and Blood Institute (U.S.)

Back to Details
This is a "connection" page, showing publications Viswanathan Ramakrishnan has written about National Heart, Lung, and Blood Institute (U.S.).
Viswanathan Ramakrishnan
Connection Strength
0.047
National Heart, Lung, and Blood Institute (U.S.)
  1. Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry. Int J Chron Obstruct Pulmon Dis. 2020; 15:3193-3199.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.